Troubles Persist For Medtronic’s HeartWare Device As FDA Announces Another Class I Recall
Executive Summary
It’s the third high-risk class I action in recent weeks related to the company’s HeartWare Ventricular Assist Device (HVAD) System. It’s also Medtronic’s sixth overall class I since the beginning of March.